These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 20730418)
1. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. van Nieuwenhuijzen PS; Long LE; Hunt GE; Arnold JC; McGregor IS Psychopharmacology (Berl); 2010 Dec; 212(4):663-74. PubMed ID: 20730418 [TBL] [Abstract][Full Text] [Related]
2. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats. van Nieuwenhuijzen PS; Li KM; Hunt GE; McGregor IS Neuropsychobiology; 2009; 60(3-4):195-203. PubMed ID: 19893336 [TBL] [Abstract][Full Text] [Related]
3. A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. van Nieuwenhuijzen PS; Kashem MA; Matsumoto I; Hunt GE; McGregor IS Neurochem Int; 2010 Jul; 56(8):871-7. PubMed ID: 20227452 [TBL] [Abstract][Full Text] [Related]
4. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry. van Nieuwenhuijzen PS; McGregor IS Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408 [TBL] [Abstract][Full Text] [Related]
5. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Clemens KJ; Cornish JL; Hunt GE; McGregor IS Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865 [TBL] [Abstract][Full Text] [Related]
6. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. McGregor IS; Gurtman CG; Morley KC; Clemens KJ; Blokland A; Li KM; Cornish JL; Hunt GE Psychopharmacology (Berl); 2003 Aug; 168(4):465-74. PubMed ID: 12700882 [TBL] [Abstract][Full Text] [Related]
7. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? McGregor IS; Callaghan PD; Hunt GE Br J Pharmacol; 2008 May; 154(2):358-68. PubMed ID: 18475254 [TBL] [Abstract][Full Text] [Related]
8. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472 [TBL] [Abstract][Full Text] [Related]
9. Intermittent ethanol exposure increases long-lasting behavioral and neurochemical effects of MDMA in adolescent mice. Rodríguez-Arias M; Maldonado C; Vidal-Infer A; Guerri C; Aguilar MA; Miñarro J Psychopharmacology (Berl); 2011 Nov; 218(2):429-42. PubMed ID: 21556804 [TBL] [Abstract][Full Text] [Related]
10. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. Cohen MA; Skelton MR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT Synapse; 2005 Sep; 57(3):148-59. PubMed ID: 15945064 [TBL] [Abstract][Full Text] [Related]
11. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Bull EJ; Hutson PH; Fone KC Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758 [TBL] [Abstract][Full Text] [Related]
12. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Hunt GE; McGregor IS; Cornish JL; Callaghan PD Brain Res Bull; 2011 Aug; 86(1-2):65-73. PubMed ID: 21745546 [TBL] [Abstract][Full Text] [Related]
13. Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats. Skelton MR; Graham DL; Schaefer TL; Grace CE; Braun AA; Burns LN; Amos-Kroohs RM; Williams MT; Vorhees CV Int J Neuropsychopharmacol; 2012 Jul; 15(6):811-24. PubMed ID: 21733225 [TBL] [Abstract][Full Text] [Related]
14. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). Morley KC; Gallate JE; Hunt GE; Mallet PE; McGregor IS Eur J Pharmacol; 2001 Dec; 433(1):91-9. PubMed ID: 11755138 [TBL] [Abstract][Full Text] [Related]
15. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999 [TBL] [Abstract][Full Text] [Related]
16. Increased Response to 3,4-Methylenedioxymethamphetamine (MDMA) Reward and Altered Gene Expression in Zebrafish During Short- and Long-Term Nicotine Withdrawal. Ponzoni L; Teh MT; Torres-Perez JV; Brennan CH; Braida D; Sala M Mol Neurobiol; 2021 Apr; 58(4):1650-1663. PubMed ID: 33236326 [TBL] [Abstract][Full Text] [Related]
17. Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration. Ball KT; Klein JE; Plocinski JA; Slack R Behav Pharmacol; 2011 Dec; 22(8):847-50. PubMed ID: 21979834 [TBL] [Abstract][Full Text] [Related]
18. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats. Thompson MR; Callaghan PD; Hunt GE; McGregor IS Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1013-21. PubMed ID: 18302974 [TBL] [Abstract][Full Text] [Related]
19. Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Ramos L; Hicks C; Caminer A; Goodwin J; McGregor IS Psychopharmacology (Berl); 2015 Jul; 232(14):2631-41. PubMed ID: 25772337 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]